drugset / Trial / NCT02534896
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designated to evaluate the safety and efficacy of Sunpharma1505 in subjects with active rheumatoid arthritis who are experiencing a flare/exacerbation.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-03
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reference1505 | Unknown | — | — |
| Subject | Sunpharma1505 | Unknown | — | — |